Virtual Incision Receives Investigational Device Exemption (IDE) to Initiate Study of First-of-its-Kind MIRA Platform
Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery
Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery
Holland, Mich., July 08, 2020 — HAPPE Spine announces that it has received notice of allowance from the U.S. Patent and Trademark Office for patent claims providing broad protections for its unique material and manufacturing technology providing fully porous, bioactive polyetheretherketone (PEEK) technology (U.S. Pat. App. No. 14/078,614).
HAPPE Spine Announces Additional Technology Patent for Porous and Bioactive PEEK Read More »
HOLLAND, Mich., Jan. 13, 2020 PRNewswire — Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its participation in Virtual Incision Corporation’s raise of $20 million in Series B+ financing. Virtual Incision is a medical device company pioneering the first-of-its-kind, miniaturized surgical robot and the
HOLLAND, Mich., December 10th, 2019 — Shoulder Innovations, (SI), a leading innovator in the development of shoulder replacement systems, announced today that they have received FDA clearance for their InSet Plus™ augmented glenoids for the InSet™ Total Shoulder System.
HOLLAND, Mich., August 20th, 2019– Genesis Innovation Group and their cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announced their investment into Grand Rapids, MI based Genesis Software Innovations, “GSI,” a company developing unique software solutions focused initially in the orthopedic space. GSI has created an innovative foundational
cultivate(MD) Announces Investment Into Genesis Software Innovations, “GSI” Read More »
HOLLAND, Mich., April 18th, 2019—Genesis Innovation Group’s Shoulder Innovations (SI) is focused on human centered design.
Shoulder Innovations Announces Publication of Long Term Data for InSet Glenoid Read More »
HOLLAND, Mich., April 11, 2019 — Genesis Innovation Group and their cultivate(MD) Capital Fund I and cultivate(MD) Seed Fund, funds focused on investments into early-stage healthcare companies with innovative technologies, announce their investments into Grand Rapids, MI based HAPPE Spine, a company with a unique fully porous, bioactive PEEK implant. This is the second round
cultivate(MD) Announces Investment Into HAPPE Spine Read More »
HOLLAND, Mich., March 11, 2019 /PRNewswire/ — Genesis Innovation Group\’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its investment into Magnesium Development Company (MDC), a company with a breakthrough magnesium (Mg) alloy technology.
cultivate(MD) Announces Investment Into Magnesium Development Company Read More »
HOLLAND, Mich., March 4th, 2019– Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its investment into Embody, Inc.
cultivate(MD) Announces Investment Into Embody, Inc. Read More »
HOLLAND, Mich., December 3rd, 2018— cultivate(MD) Seed Fund, a fund focused on investments in early-stage healthcare companies with innovative technologies, announces its investment into SpinTech.
cultivate(MD) Announces Investment Into SpinTech Read More »